Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Apple Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.67T | |
|---|---|---|
| Revenue (ttm) | 466.8B | |
| Net income (ttm) | 128.9B | |
| EPS (ttm) | $8.72 | |
| Shares out | 14.6B | |
| P/E (trailing) | 39.4x | |
| P/E (forward) | 33.6x | |
| Dividend | $1.08 (0.31%) | |
| Volume | 20,920,297 | |
| Beta | 1.07 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-09-25 | 2022-09-24 | 2023-09-30 | 2024-09-28 | 2025-09-27 | Trend |
| Revenue | $365.82B | $394.33B | $383.29B | $391.04B | $416.16B | +3.3% |
| Gross profit | $152.84B | $170.78B | $169.15B | $180.68B | $195.20B | +6.3% |
| Operating income | $108.95B | $119.44B | $114.30B | $123.22B | $133.05B | +5.1% |
| Net income | $94.68B | $99.80B | $97.00B | $93.74B | $112.01B | +4.3% |
| EPS (diluted) | $5.61 | $6.11 | $6.13 | $6.08 | $7.46 | +7.4% |
| EBITDA | $123.14B | $130.54B | $125.82B | $134.66B | $144.43B | +4.1% |
| R&D | $21.91B | $26.25B | $29.92B | $31.37B | $34.55B | +12.1% |
| SG&A | $21.97B | $25.09B | $24.93B | $26.10B | $27.60B | +5.9% |
Recent company headlines from major financial publishers.
The Base path assumes near-term demand converts, followed by slower mature growth. Sustained stronger growth or a material undershoot would disconfirm that path.
This scenario requires improved availability to convert demand into revenue and continued share reduction to support earnings per share. It fails if FY2027 revenue growth falls below 8%, or if diluted shares stop falling.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.9% | $251 | $263 | $278 | $298 | $324 |
| 7.9% | $223 | $231 | $240 | $251 | $266 |
| 8.9% | $203 | $208 | $214 | $221 | $230 |
| 9.9% | $187 | $191 | $195 | $200 | $206 |
| 10.9% | $175 | $177 | $181 | $184 | $188 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |